These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 15387315)

  • 1. [RhD immunoprophylaxis should be adjusted].
    Bock JE; Larsen JF
    Ugeskr Laeger; 2004 Aug; 166(36):3113. PubMed ID: 15387315
    [No Abstract]   [Full Text] [Related]  

  • 2. [Should the RhD prophylaxis be adjusted?].
    Georgsen J; Sprogøe U
    Ugeskr Laeger; 2004 Aug; 166(36):3072. PubMed ID: 15446237
    [No Abstract]   [Full Text] [Related]  

  • 3. [Prophylactic anti-D for RhD- patient in France: an hasty recommendation?].
    Benachi A; Nisand I
    J Gynecol Obstet Biol Reprod (Paris); 2007 Oct; 36(6):523-5. PubMed ID: 17651919
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical guidelines on anti-D prophylaxis: hasty critics?].
    Carbonne B; Marpeau L; Brossard Y
    J Gynecol Obstet Biol Reprod (Paris); 2007 Oct; 36(6):526-8. PubMed ID: 17893030
    [No Abstract]   [Full Text] [Related]  

  • 5. Preventing RhD haemolytic disease of the newborn. Guidelines are not followed in many cases.
    McFadyen IR; Martlew VJ; Howard HL; Clarke CA
    BMJ; 1998 Apr; 316(7138):1165. PubMed ID: 9569417
    [No Abstract]   [Full Text] [Related]  

  • 6. [Prevention of Rh immunization. II. Management of the risk during the second half of pregnancy and postpartum].
    Larsen JF; Bock JE; Jørgensen JR
    Ugeskr Laeger; 2004 Aug; 166(36):3078-83. PubMed ID: 15387304
    [No Abstract]   [Full Text] [Related]  

  • 7. [Prevention of Rh immunization. I. Theoretical background and management of the risk during the first half of pregnancy].
    Larsen JF; Bock JE; Jørgensen JR
    Ugeskr Laeger; 2004 Aug; 166(36):3073-8. PubMed ID: 15387303
    [No Abstract]   [Full Text] [Related]  

  • 8. [RCP: prevention in materno-fetal Rh immunization (CNGOF, December 2005). We don't have to forget to control the efficacy of these guidelines, as well as the prescription of the innovating technique in this field].
    Sagot P
    Gynecol Obstet Fertil; 2006 Apr; 34(4):358-9. PubMed ID: 16603404
    [No Abstract]   [Full Text] [Related]  

  • 9. RhD negative women. Are we ready to change practice?
    Wray J
    Pract Midwife; 2000 Oct; 3(9):26-8. PubMed ID: 12026547
    [No Abstract]   [Full Text] [Related]  

  • 10. Preventing RhD haemolytic disease of the newborn. New recommendations must be explained to GPs and midwives.
    Everett C; Wray J
    BMJ; 1998 Apr; 316(7138):1165. PubMed ID: 9569419
    [No Abstract]   [Full Text] [Related]  

  • 11. Anti-D guidelines.
    Kanjilal K; Tasker M
    Br J Fam Plann; 2000 Oct; 26(4):244. PubMed ID: 11053891
    [No Abstract]   [Full Text] [Related]  

  • 12. Rho (D) immune globulin i.v. for prevention of Rh isoimmunization and for treatment of ITP.
    Med Lett Drugs Ther; 1996 Jan; 38(966):6-8. PubMed ID: 8544794
    [No Abstract]   [Full Text] [Related]  

  • 13. Anti-D administration in early pregnancy--time for a new protocol.
    Carmody F
    Aust N Z J Obstet Gynaecol; 1996 May; 36(2):227-8. PubMed ID: 8798328
    [No Abstract]   [Full Text] [Related]  

  • 14. On the immunologic basis of Rh immune globulin (anti-D) prophylaxis.
    Kumpel BM
    Transfusion; 2006 Sep; 46(9):1652-6. PubMed ID: 16965599
    [No Abstract]   [Full Text] [Related]  

  • 15. Rhesus sensitisation.
    Allan A
    Mod Midwife; 1995 Nov; 5(11):24-6. PubMed ID: 7583418
    [No Abstract]   [Full Text] [Related]  

  • 16. Royal College of Physicians of Edinburgh/Royal College of Obstetricians and Gynaecologists Consensus Conference on anti-D prophylaxis, 7-8 April 1997.
    Br J Haematol; 1997 Jun; 97(4):927-8. PubMed ID: 9217199
    [No Abstract]   [Full Text] [Related]  

  • 17. [Recommendations for clinical practice. Prevention in maternofetal Rh immunization (December 2005)].
    Collège National des Gynécologues et Obstétriciens Français
    Gynecol Obstet Fertil; 2006 Apr; 34(4):360-5. PubMed ID: 16644259
    [No Abstract]   [Full Text] [Related]  

  • 18. Anti-D immunoglobulin in RhD prophylaxis.
    Robson SC; Lee D; Urbaniak S
    Br J Obstet Gynaecol; 1998 Feb; 105(2):129-34. PubMed ID: 9501773
    [No Abstract]   [Full Text] [Related]  

  • 19. Preventing RhD haemolytic disease of the newborn. Services should be centralised for pregnancies affected by RhD haemolytic disease.
    Craig JS; McClure BG; Tubman TR
    BMJ; 1998 May; 316(7144):1611. PubMed ID: 9616034
    [No Abstract]   [Full Text] [Related]  

  • 20. The use of anti-D immunoglobulins for rhesus prophylaxis: audit on knowledge and practices among obstetricians.
    Wee WW; Kanagalingam D
    Singapore Med J; 2009 Nov; 50(11):1054-7. PubMed ID: 19960158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.